Skip to content
Home/Companies/Biotech/Refoxy Pharmaceuticals
RP

Refoxy Pharmaceuticals

Biotech·Germany·Active·6yr hold

Refoxy Pharmaceuticals is a biotech company, headquartered in Germany.

Entry
2020
Hold
6yr
Status
Active
Est. EV
–

Who owns Refoxy Pharmaceuticals?

Refoxy Pharmaceuticals is currently owned by Apollo Health Ventures through Apollo Health Ventures Fund I (2018 vintage), since 2020. Across its history, Refoxy Pharmaceuticals has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-07-03

Apollo Health Ventures
Most recent investor
Apollo Health Ventures
Apollo Health Ventures Fund I · 2018 · Evergreen
2 ownership periods · full history below

Key facts

HQGermany
SectorBiotech
StatusActive

Ownership history

2 ownership periods · co-invest detected

Active
Co-held by Apollo Health Ventures and Boehringer Ingelheim Venture Fund since 2020.
Co-invest · 2 holders · 2020 · present
Apollo Health Ventures
Apollo Health VenturesActive
2020 · present · Apollo Health Ventures Fund I · 2018 · Evergreen
MOIC
–
Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture FundActive
2024 · present · Boehringer Ingelheim Venture Fund · 2010 · Evergreen
MOIC
–

More from Apollo Health Ventures Fund I

Other portfolio companies in the same fund.

Aeovian Pharmaceuticals
Active
BiotechUnited States· 2019
Samsara Therapeutics
Active
BiotechUnited Kingdom· 2019

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings